IDEAS home Printed from https://ideas.repec.org/p/nbr/nberwo/13125.html
   My bibliography  Save this paper

End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing

Author

Listed:
  • Avi Dor
  • Mark V. Pauly
  • Margaret A. Eichleay
  • Philip J. Held

Abstract

End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small and is correlated with overall per capita health care spending. Between-country variations in spending are reduced using an input price parity index constructed for this study. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives embedded in national programs.

Suggested Citation

  • Avi Dor & Mark V. Pauly & Margaret A. Eichleay & Philip J. Held, 2007. "End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing," NBER Working Papers 13125, National Bureau of Economic Research, Inc.
    • Handle: RePEc:nbr:nberwo:13125
    Note: EH
    as

    Download full text from publisher

    File URL: http://www.nber.org/papers/w13125.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Sarah Wordsworth & Anne Ludbrook, 2005. "Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities," Health Economics, John Wiley & Sons, Ltd., vol. 14(1), pages 93-99, January.
    2. Richard Hirth, 2007. "The organization and financing of kidney dialysis and transplant care in the United States of America," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 301-318, December.
    3. Ellis, Randall P. & McGuire, Thomas G., 1996. "Hospital response to prospective payment: Moral hazard, selection, and practice-style effects," Journal of Health Economics, Elsevier, vol. 15(3), pages 257-277, June.
    4. Office of Health Economics, 2007. "The Economics of Health Care," For School 001490, Office of Health Economics.
    5. Björn Wikström & Michael Fored & Margaret Eichleay & Stefan Jacobson, 2007. "The financing and organization of medical care for patients with end-stage renal disease in Sweden," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 269-281, December.
    6. Chalkley, Martin & Malcomson, James M, 1998. "Contracting for Health Services with Unmonitored Quality," Economic Journal, Royal Economic Society, vol. 108(449), pages 1093-1110, July.
    7. Held, Philip J. & Pauly, Mark V., 1983. "Competition and efficiency in the end stage renal disease program," Journal of Health Economics, Elsevier, vol. 2(2), pages 95-118, August.
    8. Wim Biesen & Norbert Lameire & Patrick Peeters & Raymond Vanholder, 2007. "Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 133-148, September.
    9. Giuseppe Pontoriero & Pietro Pozzoni & Lucia Vecchio & Francesco Locatelli, 2007. "International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 201-215, September.
    10. José Luño, 2007. "The organization and financing of end-stage renal disease in Spain," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 253-267, December.
    11. Anthony Harris, 2007. "The organization and funding of the treatment of end-stage renal disease in Australia," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 113-132, September.
    12. Avi Dor, 2004. "Optimal Price Rules, Administered Prices and Suboptimal Prevention: Evidence from a Medicare Program," Journal of Regulatory Economics, Springer, vol. 25(1), pages 81-104, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," NBER Working Papers 14257, National Bureau of Economic Research, Inc.
    2. Shunichi Fukuhara & Chikao Yamazaki & Yasuaki Hayashino & Takahiro Higashi & Margaret Eichleay & Takashi Akiba & Tadao Akizawa & Akira Saito & Friedrich Port & Kiyoshi Kurokawa, 2007. "The organization and financing of end-stage renal disease treatment in Japan," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 217-231, September.
    3. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," Journal of Economic Perspectives, American Economic Association, vol. 22(4), pages 27-50, Fall.
    4. Anne-Line Couillerot-Peyrondet & Cléa Sambuc & Yoël Sainsaulieu & Cécile Couchoud & Isabelle Bongiovanni-Delarozière, 2017. "A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(4), pages 459-469, May.
    5. Björn Wikström & Michael Fored & Margaret Eichleay & Stefan Jacobson, 2007. "The financing and organization of medical care for patients with end-stage renal disease in Sweden," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 269-281, December.
    6. Werner Kleophas & Helmut Reichel, 2007. "International study of health care organization and financing: development of renal replacement therapy in Germany," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 185-200, September.
    7. Cleemput, Irina & De Laet, Chris, 2013. "Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities," Health Policy, Elsevier, vol. 110(2), pages 172-179.
    8. Giuseppe Pontoriero & Pietro Pozzoni & Lucia Vecchio & Francesco Locatelli, 2007. "International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 201-215, September.
    9. Chang, Ray-E. & Hsieh, Chi-Jeng & Myrtle, Robert C., 2011. "The effect of outpatient dialysis global budget cap on healthcare utilization by end-stage renal disease patients," Social Science & Medicine, Elsevier, vol. 73(1), pages 153-159, July.
    10. José Luño, 2007. "The organization and financing of end-stage renal disease in Spain," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 253-267, December.
    11. Toni Ashton & Mark Marshall, 2007. "The organization and financing of dialysis and kidney transplantation services in New Zealand," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 233-252, December.
    12. Braden Manns & David Mendelssohn & Kenneth Taub, 2007. "The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 149-169, September.
    13. Anthony Harris, 2007. "The organization and funding of the treatment of end-stage renal disease in Australia," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 113-132, September.
    14. Tricia Nicholson & Paul Roderick, 2007. "International Study of Health Care Organization and Financing of renal services in England and Wales," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 283-299, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Avi Dor & Mark Pauly & Margaret Eichleay & Philip Held, 2007. "End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 73-111, September.
    2. Wim Biesen & Norbert Lameire & Patrick Peeters & Raymond Vanholder, 2007. "Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 133-148, September.
    3. Isabelle Durand-Zaleski & Christian Combe & Philippe Lang, 2007. "International Study of Health Care Organization and Financing for end-stage renal disease in France," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 171-183, September.
    4. Björn Wikström & Michael Fored & Margaret Eichleay & Stefan Jacobson, 2007. "The financing and organization of medical care for patients with end-stage renal disease in Sweden," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 269-281, December.
    5. Werner Kleophas & Helmut Reichel, 2007. "International study of health care organization and financing: development of renal replacement therapy in Germany," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 185-200, September.
    6. Anne-Line Couillerot-Peyrondet & Cléa Sambuc & Yoël Sainsaulieu & Cécile Couchoud & Isabelle Bongiovanni-Delarozière, 2017. "A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(4), pages 459-469, May.
    7. José Luño, 2007. "The organization and financing of end-stage renal disease in Spain," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 253-267, December.
    8. Shunichi Fukuhara & Chikao Yamazaki & Yasuaki Hayashino & Takahiro Higashi & Margaret Eichleay & Takashi Akiba & Tadao Akizawa & Akira Saito & Friedrich Port & Kiyoshi Kurokawa, 2007. "The organization and financing of end-stage renal disease treatment in Japan," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 217-231, September.
    9. Brekke, Kurt R. & Cellini, Roberto & Siciliani, Luigi & Straume, Odd Rune, 2010. "Competition and quality in health care markets: A differential-game approach," Journal of Health Economics, Elsevier, vol. 29(4), pages 508-523, July.
    10. Siciliani, Luigi & Stanciole, Anderson & Jacobs, Rowena, 2009. "Do waiting times reduce hospital costs?," Journal of Health Economics, Elsevier, vol. 28(4), pages 771-780, July.
    11. Piia Pekola & Ismo Linnosmaa & Hennamari Mikkola, 2017. "Assessing the effects of price regulation and freedom of choice on quality: evidence from the physiotherapy market," Health Economics Review, Springer, vol. 7(1), pages 1-16, December.
    12. Chalkley, Martin & McVicar, Duncan, 2008. "Choice of contracts in the British National Health Service: An empirical study," Journal of Health Economics, Elsevier, vol. 27(5), pages 1155-1167, September.
    13. Hugh Gravelle & Rita Santos & Luigi Siciliani & Rosalind Goudie, 2012. "Hospital Quality Competition Under Fixed Prices," Working Papers 080cherp, Centre for Health Economics, University of York.
    14. Tricia Nicholson & Paul Roderick, 2007. "International Study of Health Care Organization and Financing of renal services in England and Wales," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 283-299, December.
    15. Cleemput, Irina & De Laet, Chris, 2013. "Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities," Health Policy, Elsevier, vol. 110(2), pages 172-179.
    16. David Epstein & Anne Mason & Andrea Manca, 2008. "The hospital costs of care for stroke in nine European countries," Health Economics, John Wiley & Sons, Ltd., vol. 17(S1), pages 21-31, January.
    17. Cellini, Roberto & Brekke, Kurt Richard & Siciliani, Luigi, 2008. "Competition and Quality in Regulated Markets: a Differential-Game Approach," CEPR Discussion Papers 6801, C.E.P.R. Discussion Papers.
    18. Domenico Lisi & Luigi Siciliani & Odd Rune Straume, 2020. "Hospital competition under pay‐for‐performance: Quality, mortality, and readmissions," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 29(2), pages 289-314, April.
    19. Bardey, David & Canta, Chiara & Lozachmeur, Jean-Marie, 2012. "The regulation of health care providers’ payments when horizontal and vertical differentiation matter," Journal of Health Economics, Elsevier, vol. 31(5), pages 691-704.
    20. Katherine Rojahn & Suzanne Laplante & James Sloand & Claire Main & Aftab Ibrahim & Janet Wild & Nicky Sturt & Thelga Areteou & K Ian Johnson, 2016. "Remote Monitoring of Chronic Diseases: A Landscape Assessment of Policies in Four European Countries," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-15, May.

    More about this item

    JEL classification:

    • I10 - Health, Education, and Welfare - - Health - - - General
    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
    • I12 - Health, Education, and Welfare - - Health - - - Health Behavior
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nbr:nberwo:13125. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/nberrus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.